INTRODUCTION
Parkinson's Disease (PD) is the most common progressive neurode generative movement disorder which affects around 6 million people globally and the prevalence will rise with an aging population. 1, 2 Majority of the cases of PD are still considered idiopathic. There are some hypo theses of neuronal loss which involves genetically linked factors and environmental interaction factors. Ingestion or inhalation of neurotoxins (1methyl4phenyl1,2,3,6tetrahydropyridine [MPTP]), endogenous toxin releasing radical oxygen species (ROS) in brain and isoquinoline derivatives substances may cause PD. 3 Although various therapeutic agents are available to cure PD symptom atically, there are many adverse effects associated with those medications. Taken levodopa as an example, even though it remains the pharmacologic mainstay for the treatment of PD, 4 after several years of favorable responses, disabling motor complications frequently developed. 5 Other than that, numerous side effects and complications of other dopami nergic medications and surgery had been testified too. 6,7 So, these have reached our consensus that, till date, none of the drug or therapies has been convincingly shown to halt or cure the degenerative process in PD. In light of these challenges, researches into alternative neuroprotective therapies area are rising at a feverish pace. Increasing number of patients are seeking for alternative treatments such as herbal therapies. 8 Many researchers had discovered the broad therapeutic potential of a mushroom species Ganoderma lucidum (Family: Ganodermataceae). Among the bioactive elements in G. lucidum, polysaccharides, triterpenes, and peptidoglycans are three major physiologically active constituents in G. lucidum. 9,10 G. lucidum polysaccharides (GLPS) obtained by aqueous extraction are reported to exhibit a wideranging bioactivities, including antiinflammatory, hypoglycemic, antiulcer, antitumorigenic, and immunostimulating effects. 11, 12 On the other hand, the triterpenoids extract of G. lucidum (GLTT) by methanolic extraction demonstrated antipruritic effects 13 and anticancer properties 14, 15 Previous studies which stated that the extract of G. lucidum is effective to improve the function of mito chondria in aged rat brain, suggested it as a possible therapeutic appli cation against ageingassociated neurodegenerative diseases. 16 Of this interest, we hypothesize that G. lucidum extract has its therapeutic efficacy on PD. By using MPTP, PD was induced to Swiss albino mice, after which the effects of G. lucidum polysaccharide (GLPS) and triterpenoid (GLTT) fractions were investigated.
MATERIALS AND METHODS
G. lucidum was gifted by DXN Pharma Sdn Bhd., Malaysia. 1methyl 4phenyl1,2,3,6tetrahydropyridine (MPTP) was obtained from Sigma Aldrich Co, St. Louis, USA. All chemicals, consumables and solvents used in this project were of analytical grade and purchased from Bendosen laboratory chemicals, Malaysia. EDTA, diethyl ether and form aldehyde were procured from RM chemicals/ HmbG chemicals, Malaysia.
Animals
Healthy, adult, both the gender of Swiss albino mice weighing 2030 g were obtained from Central Animal house, AIMST University, Malaysia. The animals were housed in large, spacious poly acrylic cages at an ambient room temperature with 12 h light and dark cycle. The animals were fed with water and food ad libitum. The PD induced animal model study was approved by AIMST University Human and Animal Ethics Commi ttee and the study was conducted according to Animal Research Review Panel guidelines. 1 Pharmaceutical Technology Unit, Faculty of Pharmacy, AIMST University, Jalan Bedong Semeling, 08100, Bedong, Kedah Darul Aman, MALAYSIA. 2 Pharmacology Unit, AIMST University, Jalan Bedong Semeling, 08100, Bedong, Kedah Darul Aman, MALAYSIA.
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Extraction of GLPS and GLTT G. lucidum was extracted with distilled water by maceration in a dark place for 6 days. Few drops of 1% chloroform were used as preserva tive to prevent fungal growth. Later, the extract was filtered and dried at 60˚C. The semisolid form of G. lucidum polysaccharide (GLPS) extract was preserved in cold conditions until further studies. For the triterpenoid extraction, G. lucidum powder extracted with methanol by Soxhlet extraction for 24 h. The extract was evaporated to dryness on a rotary evaporator to obtain G. lucidum triterpenoid (GLTT). The extract was stored in cold conditions until further studies.
Antiparkinson activity of GLPS and GLTT Healthy Swiss albino mice were divided into five groups each of five animals as follows. Group I : Control Group II : MPTP control Group III : MPTP+GLPS 50 mg/kg Group IV : MPTP+GLTT 50 mg/kg A control group animal were administered with normal saline (1 ml/ kg) and the animals in group II to IV were administered with 3 mg/ kg MPTP (dissolved in saline), intraperitoneally for 5 consecutive days. After induction of PD, the animals in group III and IV were treated with GLPS (50 mg/kg) and GLTT (50 mg/kg). The drugs were suspended with 0.5% carboxymethyl cellulose and administered orally for 5 consecutive days. During the experiment, body weight variations, regular food and water intake was measured. Prior to the experiment and at the end of the experi ment, the rats' behavior was studied using forced swim test, grip strength test, rotarod test and locomotor activity. 17, 18 At the end of the study the rats were sacrificed and brain samples were collected and preserved in 10% neutral formalin for histopathological studies. Forced swim test: In this test, the tank with water of temperature 24°C30°C with depth that the rodent's tails and feet not touching the bottom of the tank was prepared. The rodent was then put into the tank upon which the time between the rodent to stop swimming and start sinking was recorded. The rodent was removed immediately as soon as it started to sink. The procedure was repeated for all the rodents. The water tank was then cleaned as the accumulation of faeces and urine could cause bacterial contamination. Grip strength test: The forelimb of the rodent was left to cling on a rope while its body and tail was suspended in the air above 50 cm from the ground. The time of the rodent clinging on the rope was recorded. The procedure was repeated for all 5 rodents of both control and treated group. The height between the rope and ground was ensured not be too high, to prevent the rodent hurt when falling.
Rota-rod test:
The rodent was placed on a rotarod with speed of 20 RPM. The time between rodent maintain on the rotarod until it fall was recorded. The procedure was repeated for each rodent.
Locomotor activity:
The locomotor activity of the rats was recorded in actophotometer provided with an acrylic cage and 8 beams of infrared light along both the x and yaxis. The activity of each rat was monitored at room temperature over 10 min.
Histopathological analysis
The brain samples were preserved in 10% neutral formalin for histo pathological analysis. The brain sample were embedded in paraffin after being dehydrated in alcohol and subsequently cleared with xylene. A 56 micrometer thickness of brain section were prepared from par affin blocks and stained with hematoxylin and eosin and mounted in neutral DPX medium, and the sections were examined under light microscope.
Statistical analysis
All statistical data are represented as mean ± SEM of the mentioned number of testing in five animals. One way ANOVA (Graph Pad Prism 5.00, Instat software, San Diego, CA< USA) followed by Tukey's post hoc test were used for the statistical analysis.
RESULT
The semisolid form of G. lucidum polysaccharide (GLPS) and triterpenoid (GLTT) extracts were used in this study. The percentage yield of GLPS and GLTT were found to be 8.88% and 6.67% respectively. The effect of GLPS and GLTT extract on MPTP induced behavioral alterations were summarized in Table 1 . On day of termination MPTP treated animals showed increased swimming ability, muscular strength, and increased locomotor activity. Whereas GLPS and GLTT significant ly inhibited the MPTP induced behavioral alterations. No significant alteration was observed in rotarod test. Histopathological analysis did not indicate any abnormality in the brain tissue of GLPS and GLTT treat ed animals (Figure 1 ).
DISCUSSION
Parkinson's disease is characterized by the tetrad of tremor at rest, rigidity, decreased voluntary movements, and postural instability due to depletion of dopamine levels in nigrostriatal system and loss of neu rons of nigrostriatal dopaminergic pathway. loss of dopamine producing neurons in the nigrostriatal system. The mice were injected with MPTP to induce PD, because the pathogenesis of MPTP induced PD in mice is clearly linked to a form of human parkinsonism. 19, 20 Since GLPS and GLTT, has combination benefit without toxicity which represents the desired end results in the development of effective therapeutics interven tions, it has been used for hundreds of years as a health promotion and treatment strategy. 21, 22 In the present study, MPTP administered group showed an increased neuronal and muscular activities rather than a decrease. PD was char acterized by a decreased voluntary movement, but we observed an increased motor activity after MPTP administration and this may be due to its sympathomimetic over activation or frequency of MPTP which may not be sufficient to induce PD in experimental animals. Porras et al induced PD in monkey and mouse and they found that "MPTP mouse models for instance failed to replicate symptomatic manifesta tion of PD". 22 GLPS and GLTT were found to alter the MTPT induced increase in behavioral function and this indicates that both GLPS and GLTT has some degree of neuroprotective effect. Zhang et al., and Zhou et al., studied the neuroprotective effect of G. lucidum and the effect is due to reduction in the percentage of apoptotic neurons, suppressed overexpression of active caspasses3, 8 and 9, myeloperoxidase activity, malondialdehyde levels, nitric oxide levels and inhibition of the reduc tion of Bcl2 expression. 23, 24 
CONCLUSION
The mice models injected with MPTP successfully induced reasonable extent of Parkinsonism. After employing GLPS and GLTT into the PD induced mice models, the behavioral studies of forced swim test and grip strength test reflected mean values which indicated that GPLS and GLTT held therapeutic benefit on the mice models, when compared with control.
